<DOC>
	<DOCNO>NCT03090100</DOCNO>
	<brief_summary>The purpose study evaluate efficacy guselkumab compare secukinumab treatment participant moderate severe plaque-type psoriasis .</brief_summary>
	<brief_title>A Study Evaluate Comparative Efficacy CNTO 1959 ( Guselkumab ) Secukinumab Treatment Moderate Severe Plaque-type Psoriasis</brief_title>
	<detailed_description />
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<criteria>Have diagnosis plaquetype psoriasis ( without [ Psoriatic Arthritis ] PsA ) least 6 month first administration study drug A woman childbearing potential must negative urine pregnancy test screen Week 0 agree urine pregnancy test receive injection Agree receive live virus live bacterial vaccination study , within 3 month last administration study drug Agree receive Bacille CalmetteGu√©rin ( BCG ) vaccination study , within 12 month last administration study drug Agree avoid prolong sun exposure avoid use tan booths ultraviolet light source study Has history current sign symptom severe , progressive , uncontrolled renal , cardiac , vascular , pulmonary , gastrointestinal , endocrine , neurologic , hematologic , rheumatologic , psychiatric , metabolic disturbance Has previously receive guselkumab secukinumab Has history chronic recurrent infectious disease , include limited chronic renal infection , chronic chest infection ( example bronchiectasis ) , recurrent urinary tract infection ( recurrent pyelonephritis chronic nonremitting cystitis ) , fungal infection ( mucocutaneous candidiasis ) , open , drain , infected skin wound ulcer Has history lymphoproliferative disease , include lymphoma ; history monoclonal gammopathy undetermined significance ; sign symptom suggestive possible lymphoproliferative disease , lymphadenopathy splenomegaly Is unable unwilling undergo multiple venipuncture poor tolerability lack easy access vein</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>